rnoy[/surname] [fname]A[/fname][/oauthor], [oauthor role=nd][surname]Yacobi[/surname] [fname]S[/fname][/oauthor], [oauthor role=nd][surname]Avraham[/surname] [fname]S[/fname][/oauthor], [oauthor role=nd][surname]Blumenfeld[/surname] [fname]Z[/fname][/oauthor]. [title language=en]The effect of sera from women with SLE and/or antiphospholipid syndrome on rat embryos in culture[/title][/ocontrib]. [oiserial][stitle]Reprod Toxicol[/stitle] [date dateiso="19980000"]1998[/date];[volid] 12[/volid]:[pages] 185-191[/pages][/oiserial].[/ocitat]
[ocitat][no]29[/no].[ocontrib][oauthor role=nd][surname] Ornoy[/surname] [fname]A. Yacobi S[/fname][/oauthor], [oauthor role=nd][surname]Matalon[/surname] [fname]ST[/fname][/oauthor], [oauthor role=nd][surname]Blank[/surname] [fname]M[/fname][/oauthor], [oauthor role=nd][surname]Blumenfeld[/surname] [fname]Z[/fname][/oauthor], [oauthor role=nd][surname]Miller[/surname] [fname]RK[/fname][/oauthor], [et-al]et al[/et-al]. [title language=en]The effects on antiphospholipid antibodies obtained from women with SLE/APS and associated pregnancy loss on rat embryos and placental explants in culture[/title][/ocontrib]. [oiserial][stitle]Lupus[/stitle] [date dateiso="20030000"]2003[/date];[volid] 12[/volid]:[pages] 573-578[/pages][/oiserial].[/ocitat]
[ocitat][no]30[/no].[ocontrib][oauthor role=nd][surname] Blank[/surname] [fname]M[/fname][/oauthor], [oauthor role=nd][surname]Cohen[/surname] [fname]J[/fname][/oauthor], [oauthor role=nd][surname]Toder[/surname] [fname]V[/fname][/oauthor], [oauthor role=nd][surname]Shoenfeld[/surname] [fname]Y[/fname][/oauthor]. [title language=en]Induction on anti-phospholipid syndrome in naïve mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies[/title][/ocontrib]. [oiserial][stitle]Proc Natl Acad Sci USA[/stitle] [date dateiso="19910000"]1991[/date];[volid] 88[/volid]:[pages] 3069-3073[/pages][/oiserial].[/ocitat]
[ocitat][no]31[/no].[ocontrib][oauthor role=nd][surname] Bakimer[/surname] [fname]R[/fname][/oauthor], [oauthor role=nd][surname]Fishman[/surname] [fname]P[/fname][/oauthor], [oauthor role=nd][surname]Blank[/surname] [fname]M[/fname][/oauthor], [oauthor role=nd][surname]Sredni[/surname] [fname]B[/fname][/oauthor], [oauthor role=nd][surname]Djaldetti[/surname] [fname]M[/fname][/oauthor], [oauthor role=nd][surname]Shoenfeld[/surname] [fname]Y[/fname][/oauthor]. [title language=en]Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3)[/title][/ocontrib]. [oiserial][stitle]J Clin Invest[/stitle] [date dateiso="19920000"]1992[/date];[volid] 89[/volid]:[pages] 1558-1563[/pages][/oiserial].[/ocitat]
[ocitat][no]32[/no].[ocontrib][oauthor role=nd][surname] Rand[/surname] [fname]JH[/fname][/oauthor]. [title language=en]The antiphospholipid syndrome[/title][/ocontrib]. [oiserial][stitle]Annu Rev Med[/stitle] [date dateiso="20030000"]2003[/date];[volid] 54[/volid]:[pages] 409-424[/pages][/oiserial].[/ocitat]
[ocitat][no]33[/no].[ocontrib][oauthor role=nd][surname] Shoenfeld[/surname] [fname]Y[/fname][/oauthor], [oauthor role=nd][surname]Sherer[/surname] [fname]Y[/fname][/oauthor], [oauthor role=nd][surname]Fishman[/surname] [fname]P[/fname][/oauthor]. [title language=en]Interleukin-3 and pregnancy loss in antiphospholipid syndrome[/title][/ocontrib]. [oiserial][stitle]Scand J Rheumatol[/stitle] [date dateiso="19980000"]1998[/date];[volid] 107[/volid]:[pages] 19-22[/pages][/oiserial].[/ocitat]
[ocitat][no]34[/no].[ocontrib][oauthor role=nd][surname] Carp[/surname] [fname]HJA[/fname][/oauthor]. [title language=en]Antiphospholipid syndrome in pregnancy[/title][/ocontrib]. [oiserial][stitle]Curr Opin Obstet Gynecol[/stitle] [date dateiso="20040000"]2004[/date];[volid] 16[/volid]:[pages] 129-135[/pages][/oiserial].[/ocitat]
[ocitat][no]35[/no].[ocontrib][oauthor role=nd][surname] Oosting[/surname] [fname]JD[/fname][/oauthor], [oauthor role=nd][surname]Derksen[/surname] [fname]RHWM[/fname][/oauthor], [oauthor role=nd][surname]Bobbink[/surname] [fname]IWG[/fname][/oauthor], [oauthor role=nd][surname]Hackeng[/surname] [fname]TM[/fname][/oauthor], [oauthor role=nd][surname]Bruma[/surname] [fname]BN[/fname][/oauthor], [oauthor role=nd][surname]de Groot[/surname] [fname] PG[/fname][/oauthor]. [title language=en]Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C or protein S[/title]:[subtitle] an explanation for their pathogenic mechanism?[/subtitle][/ocontrib]. [oiserial][stitle]Blood[/stitle] [date dateiso="19930000"]1993[/date];[volid] 81[/volid]:[pages] 2618-2625[/pages][/oiserial].[/ocitat]
[ocitat][no]36[/no].[ocontrib][oauthor role=nd][surname] Wurm[/surname] [fname]H[/fname][/oauthor]. [title language=en]B2-Glycoprotein-1 (apolipoprotein H) interactions with phospholipid vesicles[/title][/ocontrib]. [oiserial][stitle]Int J Biochem[/stitle] [date dateiso="19840000"]1984[/date];[volid] 16[/volid]:[pages] 511-515[/pages][/oiserial].[/ocitat]
[ocitat][no]37[/no].[ocontrib][oauthor role=nd][surname] Tincani[/surname] [fname]A[/fname][/oauthor], [oauthor role=nd][surname]Balestrieri[/surname] [fname]G[/fname][/oauthor], [oauthor role=nd][surname]Allegri[/surname] [fname]F[/fname][/oauthor], [oauthor role=nd][surname]Cinquini[/surname] [fname]M[/fname][/oauthor], [oauthor role=nd][surname]Vianelli[/surname] [fname]M[/fname][/oauthor], [oauthor role=nd][surname]Taglietti[/surname] [fname]M[/fname][/oauthor], [et-al]et al[/et-al]. [title language=en]Overview on anticardiolipin ELISA standardization[/title][/ocontrib]. [oiserial][stitle]J Autoimmun[/stitle] [date dateiso="20000000"]2000[/date];[volid] 15[/volid]:[pages] 195-197[/pages][/oiserial].[/ocitat]
[ocitat][no]38[/no].[ocontrib][oauthor role=nd][surname] Roubey[/surname] [fname]R[/fname][/oauthor]. [title language=en]Tissue factor pathway and the antiphospholipid syndrome[/title][/ocontrib]. [oiserial][stitle]J Autoimmun[/stitle] [date dateiso="20000000"]2000[/date];[volid] 15[/volid]:[pages] 217-220[/pages][/oiserial].[/ocitat]
[ocitat][no]39[/no].[ocontrib][oauthor role=nd][surname] Rand[/surname] [fname]JH[/fname][/oauthor], [oauthor role=nd][surname]Wu[/surname] [fname]X[/fname][/oauthor], [oauthor role=nd][surname]Andree[/surname] [fname]HAM[/fname][/oauthor], [oauthor role=nd][surname]Lockwood[/surname] [fname]CJ[/fname][/oauthor], [oauthor role=nd][surname]Guller[/surname] [fname]S[/fname][/oauthor], [oauthor role=nd][surname]Scher[/surname] [fname]J[/fname][/oauthor], [et-al]et al[/et-al]. [title language=en]Pregnancy loss in the antiphospholipid-antibody syndrome-a possible thrombogenic mechanism[/title][/ocontrib]. [oiserial][stitle]N Engl J Med[/stitle] [date dateiso="19970000"]1997[/date];[volid] 337[/volid]:[pages] 154-160[/pages][/oiserial].[/ocitat]
[ocitat][no]40[/no].[ocontrib][oauthor role=nd][surname] Meroni[/surname] [fname]PL[/fname][/oauthor], [oauthor role=nd][surname]di[/surname] [fname]Simone N[/fname][/oauthor], [oauthor role=nd][surname]Testoni[/surname] [fname]C[/fname][/oauthor], [oauthor role=nd][surname]D'Asta[/surname] [fname]M[/fname][/oauthor], [oauthor role=nd][surname]Acaia[/surname] [fname]B[/fname][/oauthor], [oauthor role=nd][surname]Caruso[/surname] [fname]A[/fname][/oauthor]. [title language=en]Antiphospholipid antibodies as a cause of pregnancy loss[/title][/ocontrib]. [oiserial][stitle]Lupus[/stitle] [date dateiso="20040000"]2004[/date];[volid] 13[/volid]:[pages] 649-652[/pages][/oiserial].[/ocitat]
[ocitat][no]41[/no].[ocontrib][oauthor role=nd][surname] Girardi[/surname] [fname]G[/fname][/oauthor], [oauthor role=nd][surname]Bulla[/surname] [fname]R[/fname][/oauthor], [oauthor role=nd][surname]Salmon[/surname] [fname]JE[/fname][/oauthor], [oauthor role=nd][surname]Tedesco[/surname] [fname]F[/fname][/oauthor]. [title language=en]The complement system in the pathophysiology of pregnancy[/title][/ocontrib]. [oiserial][stitle]Mol Immunol[/stitle] [date dateiso="20060000"]2006[/date];[volid] 43[/volid]([issueno]1-2[/issueno]):[pages] 68-77[/pages][/oiserial].[/ocitat]
[ocitat][no]42[/no]. [ocontrib][oauthor role=nd][surname]Salmon[/surname] [fname]JE[/fname][/oauthor], [oauthor role=nd][surname]Girardi [/surname][fname]G[/fname][/oauthor]. [title language=en]Antiphospholipid antibodies and pregnancy loss[/title]: [subtitle]A disorder of inflammation[/subtitle][/ocontrib]. [oiserial][stitle]J Reprod Immunol[/stitle]. [date dateiso="20070000"]2007[/date]; [date dateiso="20000404"]Apr 4[/date]; [Epub ahead of print][/oiserial].[/ocitat]
[ocitat][no]43[/no].[ocontrib][oauthor role=nd][surname] Girardi[/surname] [fname]G[/fname][/oauthor]. [title language=en]Heparin treatment in pregnancy loss[/title]:[subtitle] Potential therapeutic benefits beyond anticoagulation[/subtitle][/ocontrib]. [oiserial][stitle]J Reprod Immunol[/stitle] [date dateiso="20050000"]2005[/date];[volid] 66[/volid]([issueno]1[/issueno]):[pages] 45-51[/pages][/oiserial].[/ocitat]
[ocitat][no]44[/no].[ocontrib][oauthor role=nd][surname] Salmon[/surname] [fname]JE[/fname][/oauthor], [oauthor role=nd][surname]Girardi[/surname] [fname]G[/fname][/oauthor], [oauthor role=nd][surname]Lockshin[/surname] [fname]MD[/fname][/oauthor]. [title language=en]The antiphospholipid syndrome as a disorder initiated by inflammation[/title]:[subtitle] implications for the therapy of pregnant patients[/subtitle][/ocontrib]. [oiserial][stitle]Nat Clin Pract Rheumatol[/stitle] [date dateiso="20070000"]2007[/date];[volid] 3[/volid]([issueno]3[/issueno]):[pages] 140-147[/pages][/oiserial].[/ocitat]
[ocitat][no]45[/no].[ocontrib][oauthor role=nd][surname] Lassere[/surname] [fname]M[/fname][/oauthor], [oauthor role=nd][surname]Empson[/surname] [fname]M[/fname][/oauthor]. [title language=en]Treatment of antiphospholipid syndrome in pregnancy[/title][/ocontrib]. [oiserial][stitle]A systematic review of randomized therapeutic trials. Thromb Res[/stitle] [date dateiso="20040000"]2004[/date];[volid] 114[/volid]:[pages] 419-426[/pages][/oiserial].[/ocitat]
[ocitat][no]46[/no].[ocontrib][oauthor role=nd][surname] Ruffatti[/surname] [fname]A[/fname][/oauthor], [oauthor role=nd][surname]Favaro[/surname] [fname]M[/fname][/oauthor], [oauthor role=nd][surname]Tonello[/surname] [fname]M[/fname][/oauthor], [oauthor role=nd][surname]De Silvestro[/surname] [fname] G[/fname][/oauthor], [oauthor role=nd][surname]Pengo[/surname] [fname]V[/fname][/oauthor], [oauthor role=nd][surname]Fais[/surname] [fname]G[/fname][/oauthor], [et-al]et al[/et-al]. [title language=en]Efficacy and safety of nadroparin in the treatment of pregnant women with antiphospholipid syndrome[/title]:[subtitle] a prospective cohort study[/subtitle][/ocontrib]. [oiserial][stitle]Lupus[/stitle] [date dateiso="20050000"]2005[/date];[volid] 14[/volid]([issueno]2[/issueno]):[pages] 120-128[/pages][/oiserial].[/ocitat]
[ocitat][no]47[/no].[ocontrib][oauthor role=nd][surname] Bates[/surname] [fname]SM[/fname][/oauthor], [oauthor role=nd][surname]Greer[/surname] [fname]IA[/fname][/oauthor], [oauthor role=nd][surname]Hirsh[/surname] [fname]J[/fname][/oauthor], [oauthor role=nd][surname]Ginsberg[/surname] [fname]JS[/fname][/oauthor]. [title language=en]Use of antithrombotic agents during pregnancy[/title]:[subtitle] the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy[/subtitle][/ocontrib]. [oiserial][stitle]Chest[/stitle] [date dateiso="20040000"]2004[/date];[volid] 126[/volid]( [suppl]3 [/suppl]Suppl):[pages] 627S-644S[/pages][/oiserial].[/ocitat]
[ocitat][no]48[/no].[ocontrib][oauthor role=nd][surname] Lockshin[/surname] [fname]MD[/fname][/oauthor], [oauthor role=nd][surname]Druzin[/surname] [fname]ML[/fname][/oauthor], [oauthor role=nd][surname]Qamar[/surname] [fname]T[/fname][/oauthor]. [title language=en]Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody[/title][/ocontrib]. [oiserial][stitle]Am J Obstet Gynecol[/stitle] [date dateiso="19890000"]1989[/date];[volid] 160[/volid]:[pages] 439-443[/pages][/oiserial].[/ocitat]
[ocitat][no]49[/no].[ocontrib][oauthor role=nd][surname] Triolo[/surname] [fname]G[/fname][/oauthor], [oauthor role=nd][surname]Ferrante[/surname] [fname]A[/fname][/oauthor], [oauthor role=nd][surname]Accardo-Palumbo[/surname] [fname]A[/fname][/oauthor], [oauthor role=nd][surname]Ciccia[/surname] [fname]F[/fname][/oauthor], [oauthor role=nd][surname]Cadelo[/surname] [fname]M[/fname][/oauthor], [oauthor role=nd][surname]Castelli[/surname] [fname]A[/fname][/oauthor], [et-al]et al[/et-al]. [title language=en]IVIG in APS pregnancy[/title][/ocontrib]. [oiserial][stitle]Lupus[/stitle] [date dateiso="20040000"]2004[/date];[volid] 13[/volid]([issueno]9[/issueno]):[pages] 731-735[/pages][/oiserial].[/ocitat]
[ocitat][no]50[/no].[ocontrib][oauthor role=nd][surname] Ruffatti[/surname] [fname]A[/fname][/oauthor], [oauthor role=nd][surname]Marson[/surname] [fname]P[/fname][/oauthor], [oauthor role=nd][surname]Pengo[/surname] [fname]V[/fname][/oauthor], [oauthor role=nd][surname]Favaro[/surname] [fname]M[/fname][/oauthor], [oauthor role=nd][surname]Tonello[/surname] [fname]M[/fname][/oauthor], [oauthor role=nd][surname]Bortolati[/surname] [fname]M[/fname][/oauthor], [et-al]et al[/et-al]. [title language=en]Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome[/title][/ocontrib]. [oiserial][stitle]A report of 9 cases and a review of the literature. Autoimmun Rev[/stitle] [date dateiso="20070000"]2007[/date];[volid] 6[/volid]([issueno]3[/issueno]):[pages] 196-202[/pages][/oiserial].[/ocitat]
[ocitat][no]51[/no].[ocontrib][oauthor role=nd][surname] Parke[/surname] [fname]AL[/fname][/oauthor], [oauthor role=nd][surname]Rothfield[/surname] [fname]NF[/fname][/oauthor]. [title language=en]Antimalarial drugs in pregnancy-the North American experience[/title][/ocontrib]. [oiserial][stitle]Lupus[/stitle] [date dateiso="19960000"]1996[/date];[volid] 5[/volid]:[pages] 67-69[/pages][/oiserial].[/ocitat]
[ocitat][no]52[/no].[ocontrib][oauthor role=nd][surname] Ramsey-Goldman[/surname] [fname]R[/fname][/oauthor], [oauthor role=nd][surname]Schilling[/surname] [fname]E[/fname][/oauthor]. [title language=en]Immunosupressive drug use during pregnancy[/title][/ocontrib]. [oiserial][stitle]Rheum Dis Clin North Am[/stitle] [date dateiso="19970000"]1997[/date];[volid] 23[/volid]:[pages] 149-167[/pages][/oiserial].[/ocitat]
[ocitat][no]53[/no].[ocontrib][oauthor role=nd][surname] Hench[/surname] [fname]PS[/fname][/oauthor]. [title language=en]The ameliorating effect of pregnancy on chronic atrophic (infectious rheumatoid) arthritis, fibrositis and intermittent hydrarthrosis[/title][/ocontrib]. [oiserial][stitle]Mayo Clin Proc[/stitle] [date dateiso="19380000"]1938[/date];[volid] 13[/volid]:[pages] 161-167[/pages][/oiserial].[/ocitat]
[ocitat][no]54[/no].[ocontrib][oauthor role=nd][surname] Nelson[/surname] [fname]JD[/fname][/oauthor], [oauthor role=nd][surname]Ostensen[/surname] [fname]M[/fname][/oauthor]. [title language=en]Pregnancy and rheumatoid arthritis[/title][/ocontrib]. [oiserial][stitle]Rheum Dis Clin North Am[/stitle] [date dateiso="19970000"]1997[/date];[volid] 23[/volid]:[pages] 195-212[/pages][/oiserial].[/ocitat]
[ocitat][no]55[/no].[ocontrib][oauthor role=nd][surname] Vroom[/surname] [fname]F[/fname][/oauthor], [oauthor role=nd][surname]de[/surname] [fname]Walle H,van de Laar M,Brouwers J,de Jong-van den Berg L[/fname][/oauthor]. [title language=en]Disease-Modifying Antirheumatic Drugs in Pregnancy[/title][/ocontrib]. [oiserial][stitle]Current Status and Implications for the Future. Drug Safety[/stitle] [date dateiso="20060000"]2006[/date];[volid] 29[/volid]:[pages] 845-863[/pages][/oiserial].[/ocitat]
[ocitat][no]56[/no].[ocontrib][oauthor role=nd][surname] Hyrich[/surname] [fname]K[/fname][/oauthor], [oauthor role=nd][surname]Symmons[/surname] [fname]D[/fname][/oauthor], [oauthor role=nd][surname]Watson[/surname] [fname]K[/fname][/oauthor], [oauthor role=nd][surname]Silman[/surname] [fname]A[/fname][/oauthor]. [title language=en]Pregnancy outcome in women who were exposed to anti-tumor necrosis factor agents[/title]:[subtitle] results from a national population register[/subtitle][/ocontrib]. [oiserial][stitle]Arthritis Rheum[/stitle] [date dateiso="20060000"]2006[/date];[volid] 54[/volid]:[pages] 2701-2702[/pages][/oiserial].[/ocitat]
[ocitat][no]57[/no].[ocontrib][oauthor role=nd][surname] Steen[/surname] [fname]VD[/fname][/oauthor]. [title language=en]Systemic sclerosis[/title][/ocontrib]. [oiserial][stitle]Rheum Dis Clin North Am[/stitle] [date dateiso="19900000"]1990[/date];[volid] 16[/volid]:[pages] 641-654[/pages][/oiserial].[/ocitat]
[ocitat][no]58[/no].[ocontrib][oauthor role=nd][surname] Steen[/surname] [fname]VD[/fname][/oauthor]. [title language=en]Scleroderma and Pregnancy[/title][/ocontrib]. [oiserial][stitle]Rheum Dis Clin North Am[/stitle] [date dateiso="19970000"]1997[/date];[volid] 23[/volid]:[pages] 133-147[/pages][/oiserial].[/ocitat]
[ocitat][no]59[/no].[ocontrib][oauthor role=nd][surname] Steen[/surname] [fname]VD[/fname][/oauthor], [oauthor role=nd][surname]Brodeur[/surname] [fname]M[/fname][/oauthor], [oauthor role=nd][surname]Conte[/surname] [fname]C[/fname][/oauthor]. [title language=en]Prospective pregnancy (PG) study in women with systemic sclerosis[/title][/ocontrib]. [oiserial][stitle]Arthritis Rheum[/stitle] [date dateiso="19960000"]1996[/date];[volid] 39[/volid]:[pages] 151[/pages][/oiserial].[/ocitat]
[ocitat][no]60[/no].[ocontrib][oauthor role=nd][surname] Chung[/surname] [fname]L[/fname][/oauthor], [oauthor role=nd][surname]Flyckt[/surname] [fname]R[/fname][/oauthor], [oauthor role=nd][surname]Colón[/surname] [fname]I[/fname][/oauthor], [oauthor role=nd][surname]Shah[/surname] [fname]A[/fname][/oauthor], [oauthor role=nd][surname]Druzin[/surname] [fname]M[/fname][/oauthor], [oauthor role=nd][surname]Chakravarty[/surname] [fname]EF[/fname][/oauthor]. [title language=en]Outcome of pregnancies complicated by systemic sclerosis and mixed connective tissue disease[/title][/ocontrib]. [oiserial][stitle]Lupus[/stitle] [date dateiso="20060000"]2006[/date];[volid] 15[/volid]:[pages] 595-599[/pages][/oiserial].[/ocitat]
[ocitat][no]61[/no].[ocontrib][oauthor role=nd][surname] Traub[/surname] [fname]YM[/fname][/oauthor], [oauthor role=nd][surname]Shapiro[/surname] [fname]AP[/fname][/oauthor], [oauthor role=nd][surname]Rodnan[/surname] [fname]GP[/fname][/oauthor], [oauthor role=nd][surname]Medsger[/surname] [fname]TA[/fname][/oauthor], [oauthor role=nd][surname]McDonald[/surname] [fname]RH Jr[/fname][/oauthor], [oauthor role=nd][surname]Steen[/surname] [fname]VD[/fname][/oauthor], [et-al]et al[/et-al]. [title language=en]Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis: report of a 25 year experience with 68 cases[/title][/ocontrib]. [oiserial][stitle]Medicine[/stitle] [date dateiso="19840000"]1984[/date];[volid] 62[/volid]:[pages] 335-352[/pages][/oiserial].[/ocitat]
[ocitat][no]62[/no].[ocontrib][oauthor role=nd][surname] Zeidler[/surname] [fname]H[/fname][/oauthor], [oauthor role=nd][surname]Mau[/surname] [fname]W[/fname][/oauthor], [oauthor role=nd][surname]Khan[/surname] [fname]MA[/fname][/oauthor]. [title language=en]Undifferentiated spondyloarthropathies[/title][/ocontrib]. [oiserial][stitle]Rheum Dis Clin North Am[/stitle] [date dateiso="19920000"]1992[/date];[volid] 18[/volid]:[pages] 187-202[/pages][/oiserial].[/ocitat]
[ocitat][no]63[/no].[ocontrib][oauthor role=nd][surname] Kiratiseavee[/surname] [fname]S[/fname][/oauthor], [oauthor role=nd][surname]Brent[/surname] [fname]LH[/fname][/oauthor]. [title language=en]Spondyloarthropathies: Using presentation to make the diagnosis[/title][/ocontrib]. [oiserial][stitle]Clevel Clin J Medicine[/stitle] [date dateiso="20040000"]2004[/date];[volid] 71[/volid]:[pages] 194-206[/pages][/oiserial].[/ocitat]
[ocitat][no]64[/no].[ocontrib][oauthor role=nd][surname] Takaya[/surname] [fname]M[/fname][/oauthor], [oauthor role=nd][surname]Ichikawa[/surname] [fname]Y[/fname][/oauthor], [oauthor role=nd][surname]Shimizu[/surname] [fname]H[/fname][/oauthor], [oauthor role=nd][surname]Uchiyama[/surname] [fname]M[/fname][/oauthor], [oauthor role=nd][surname]Moriuchi[/surname] [fname]J[/fname][/oauthor], [oauthor role=nd][surname]Arimori[/surname] [fname]S[/fname][/oauthor]. [title language=en]Sjögren's syndrome and pregnancy[/title][/ocontrib]. [oiserial][stitle]Tokai J Exp Clin Med[/stitle] [date dateiso="19910000"]1991[/date];[volid] 16[/volid]:[pages] 83-88[/pages][/oiserial].[/ocitat]
[ocitat][no]65[/no].[ocontrib][oauthor role=nd][surname] Haga[/surname] [fname]HJ[/fname][/oauthor], [oauthor role=nd][surname]Gjesdal[/surname] [fname]CG[/fname][/oauthor], [oauthor role=nd][surname]Koksvik[/surname] [fname]HS[/fname][/oauthor], [oauthor role=nd][surname]Skomsvoll[/surname] [fname]JF[/fname][/oauthor], [oauthor role=nd][surname]Irgens[/surname] [fname]LM[/fname][/oauthor], [oauthor role=nd][surname]Ostensen[/surname] [fname]M[/fname][/oauthor]. [title language=en]Pregnancy outcome in patients with primary Sjögren's syndrome[/title].[subtitle] A case-control study[/subtitle][/ocontrib]. [oiserial][stitle]J Rheumatol[/stitle] [date dateiso="20050000"]2005[/date];[volid] 32[/volid]([issueno]9[/issueno]):[pages] 1734-1736[/pages][/oiserial].[/ocitat]
[ocitat][no]66[/no].[ocontrib][oauthor role=nd][surname] Julkunen[/surname] [fname]H[/fname][/oauthor], [oauthor role=nd][surname]Kaaja[/surname] [fname]R[/fname][/oauthor], [oauthor role=nd][surname]Kurki[/surname] [fname]P[/fname][/oauthor], [oauthor role=nd][surname]Palosuo[/surname] [fname]T[/fname][/oauthor], [oauthor role=nd][surname]Friman[/surname] [fname]C[/fname][/oauthor]. [title language=en]Fetal outcome in women with primary Sjögren's syndrome[/title].[subtitle] A retrospective case-control study[/subtitle][/ocontrib]. [oiserial][stitle]Clin Exp Rheum[/stitle] [date dateiso="19950000"]1995[/date];[volid] 13[/volid]:[pages] 65-71[/pages][/oiserial].[/ocitat]
[ocitat][no]67[/no].[ocontrib][oauthor role=nd][surname] Poncelet C,[/surname] [fname]Perdu M[/fname][/oauthor], [oauthor role=nd][surname]Levy-Weil F,[/surname] [fname]Philippe HJ[/fname][/oauthor], [oauthor role=nd][surname]Nisand[/surname] [fname]I[/fname][/oauthor]. [title language=en]Reflex sympathetic dystrophy in pregnancy[/title]:[subtitle] nine cases and a review of the literature[/subtitle][/ocontrib]. [oiserial][stitle]Eur J Obstet Gynecol Reprod Biol[/stitle] [date dateiso="19990000"]1999[/date];[volid] 86[/volid]([issueno]1[/issueno]):[pages] 55-63[/pages][/oiserial].[/ocitat]
[ocitat][no]68[/no].[ocontrib][oauthor role=nd][surname] John[/surname] [fname]J[/fname][/oauthor]. [title language=en]Cush. Safety overview of new disease-modifying antirheumatic drugs. [/title][/ocontrib] [oiserial][stitle] Rheum Dis Clin N Am[/stitle] [date dateiso="20040000"]2004[/date];[volid] 30[/volid]:[pages] 237-255[/pages][/oiserial].[/ocitat][/other][/back] [/article]